254 related articles for article (PubMed ID: 24965457)
1. Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.
Siciliano NA; Hersperger AR; Lacuanan AM; Xu RH; Sidney J; Sette A; Sigal LJ; Eisenlohr LC
J Virol; 2014 Sep; 88(17):10078-91. PubMed ID: 24965457
[TBL] [Abstract][Full Text] [Related]
2. Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity.
Hersperger AR; Siciliano NA; Eisenlohr LC
J Virol; 2012 Jul; 86(13):7298-309. PubMed ID: 22532670
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.
Fang M; Remakus S; Roscoe F; Ma X; Sigal LJ
J Virol; 2015 Jan; 89(1):776-83. PubMed ID: 25355885
[TBL] [Abstract][Full Text] [Related]
4. Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model.
Kumar A; Suryadevara NC; Wolf KJ; Wilson JT; Di Paolo RJ; Brien JD; Joyce S
Sci Rep; 2020 Aug; 10(1):13167. PubMed ID: 32759969
[TBL] [Abstract][Full Text] [Related]
5. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia Virus Vectors Targeting Peptides for MHC Class II Presentation to CD4
Hobbs SJ; Harbour JC; Yates PA; Ortiz D; Landfear SM; Nolz JC
Immunohorizons; 2020 Jan; 4(1):1-13. PubMed ID: 31896555
[TBL] [Abstract][Full Text] [Related]
7. Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host.
Fang M; Sigal LJ
J Immunol; 2006 Dec; 177(11):8027-36. PubMed ID: 17114476
[TBL] [Abstract][Full Text] [Related]
8. Correlates of protective immunity in poxvirus infection: where does antibody stand?
Panchanathan V; Chaudhri G; Karupiah G
Immunol Cell Biol; 2008 Jan; 86(1):80-6. PubMed ID: 17923850
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses.
Moutaftsi M; Bui HH; Peters B; Sidney J; Salek-Ardakani S; Oseroff C; Pasquetto V; Crotty S; Croft M; Lefkowitz EJ; Grey H; Sette A
J Immunol; 2007 Jun; 178(11):6814-20. PubMed ID: 17513729
[TBL] [Abstract][Full Text] [Related]
10. Analysis of MHC Class I Processing Pathways That Generate a Response to Vaccinia Virus Late Proteins.
Niu TK; Princiotta MF; Sei JJ; Norbury CC
Immunohorizons; 2019 Dec; 3(12):559-572. PubMed ID: 31791977
[TBL] [Abstract][Full Text] [Related]
11. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
Earl PL; Americo JL; Moss B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
[TBL] [Abstract][Full Text] [Related]
12. Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response.
Yuen TJ; Flesch IE; Hollett NA; Dobson BM; Russell TA; Fahrer AM; Tscharke DC
J Virol; 2010 Oct; 84(19):10220-9. PubMed ID: 20668091
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.
Knudson CJ; Férez M; Alves-Peixoto P; Erkes DA; Melo-Silva CR; Tang L; Snyder CM; Sigal LJ
J Virol; 2021 Sep; 95(19):e0056621. PubMed ID: 34260270
[TBL] [Abstract][Full Text] [Related]
14. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose.
Hu Z; Molloy MJ; Usherwood EJ
Cell Mol Immunol; 2016 Jan; 13(1):82-93. PubMed ID: 25544501
[TBL] [Abstract][Full Text] [Related]
15. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.
Paran N; Lustig S; Zvi A; Erez N; Israely T; Melamed S; Politi B; Ben-Nathan D; Schneider P; Lachmi B; Israeli O; Stein D; Levin R; Olshevsky U
Virol J; 2013 Jul; 10():229. PubMed ID: 23842430
[TBL] [Abstract][Full Text] [Related]
16. Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.
Volz A; Langenmayer M; Jany S; Kalinke U; Sutter G
J Virol; 2014 Sep; 88(18):10946-57. PubMed ID: 25008931
[TBL] [Abstract][Full Text] [Related]
17. Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses.
Holechek SA; Denzler KL; Heck MC; Schriewer J; Buller RM; Legrand FA; Verardi PH; Jones LA; Yilma T; Jacobs BL
PLoS One; 2013; 8(10):e77879. PubMed ID: 24147092
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of vaccinia virus E3 and K3 cannot rescue ectromelia virus replication in rabbit RK13 cells.
Hand ES; Haller SL; Peng C; Rothenburg S; Hersperger AR
PLoS One; 2015; 10(3):e0119189. PubMed ID: 25734776
[TBL] [Abstract][Full Text] [Related]
19. Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection.
Samuelsson C; Hausmann J; Lauterbach H; Schmidt M; Akira S; Wagner H; Chaplin P; Suter M; O'Keeffe M; Hochrein H
J Clin Invest; 2008 May; 118(5):1776-84. PubMed ID: 18398511
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell responses to vaccinia virus envelope proteins.
Tang J; Murtadha M; Schnell M; Eisenlohr LC; Hooper J; Flomenberg P
J Virol; 2006 Oct; 80(20):10010-20. PubMed ID: 17005679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
